ArticleProceedings of SPIE--the International Society for Optical Engineering2025
A technical assessment of latent diffusion for Alzheimer's Disease progression.
Article in Proceedings of SPIE--the International Society for Optical Engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Modeling a Shared Reality of Tractography through Varied Structural Imaging.bioRxiv : the preprint server for biology · 2026Article
- Modeling a Shared Reality of Tractography through Varied Structural Imaging.Proceedings of SPIE--the International Society for Optical Engineering · 2026Article
- Brain Latent Progression: Individual-based spatiotemporal disease progression on 3D Brain MRIs via latent diffusion.Medical image analysis · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Latent Diffusion Models (LDMs) introduce exciting opportunities in medical imaging, from disease progression prediction to interpolation to generate entire datasets of rare data. The stochastic nature of generative models makes it challenging to validate their outputs and assess their robustness across diverse datasets. BrLP, a state-of-the-art LDM for T1-weighted (T1w) images that incorporates auxiliary brain volume information, has been evaluated on Alzheimer's Disease (AD) progression, and achieves structural similarity index (SSIM) of 0.91 ± 0.03. In this work, we conducted a pilot study of the BrLP model using the Baltimore Longitudinal Study of Aging (BLSA) dataset. Our objectives are to (1) evaluate the model performance on an external dataset using pretrained image-based and brain image-based metrics such as mean squared error (MSE), similarity index, and mean absolute error (MAE) between conditional and unconditional brain regions; and (2) determine if a harmonization step, in addition to the proposed model's preprocessing steps, is required to improve performance. We found that the BrLP is robust to T1w imaging scanner effects, and harmonization is not required. However, there exists a bias toward a younger population compared to the BLSA cohort (BrLP reported 0.91 ± 0.03 SSIM in a cohort with age range 74 ±7 years; SSIM in our experiment is 0.91 ± 0.03 in cognitively normal subjects with age range 79.47 years ± 7.35 and AD cohort 0.90 ± 0.012 with age range 83.73 years ± 6.01). Interestingly, when the model's input was changed to simulate AD progression instead of normal aging, a higher SSIM of 0.91 ± 0.0012 was achieved compared to a ground truth non-AD scan, suggesting a potential mismatch. However, the resulting lower conditional volume regions function as expected. The model's architecture shows promise for longitudinal T1w imaging studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.